Angels Den for health care helps bring scientists' pitches to life | CBC News
Briefly

Angels Den for health care helps bring scientists' pitches to life | CBC News
"Six teams of St. Michael's Hospital's top scientists share their groundbreaking research ideas to judges, jurors and over 1,000 attendees. The teams have just a few minutes to pitch their ideas, competing for $700,000 in prizes to put toward the research, as well as $300,000 in grants. The event, led by St. Michael's Hospital Foundation, will hear pitches ranging from a device that quickly clears blocked dialysis catheters avoiding high-risk surgeries to physicianparamedic teams that bring lifesaving ER care directly to trauma patients at the scene."
"Labouta says the challenge is that three out of four pregnant women take medication, yet for a high percentage of the drugs, it's not known whether they're safe for the baby. In some cases, she says, the medications actually may cause harm to the baby. Labouta and her lab partner, Perez Davalos, are developing a breakthrough drug delivery system that targets treatment to the mother only, shielding the baby from potential unknown side effects."
"From new artificial intelligence tools to innovative medical devices, a research competition at St. Michael's Hospital is taking pitches on how to improve the health-care system, and bringing them to life. The competition, called Angels Den, is now in its 11th year and will take place at Koerner Hall Wednesday with scientists vying for prizes that could change lives."
A research competition at St. Michael's Hospital, Angels Den, invites top scientists to present rapid pitches to judges, jurors and a large audience for significant funding. Six finalist teams compete for $700,000 in prizes and $300,000 in grants to advance translational projects. Proposed innovations include devices that clear blocked dialysis catheters to avoid high-risk surgery, physician-paramedic teams that deliver ER care at trauma scenes, and novel drug-delivery platforms for pregnancy. One finalist is developing nanoparticles to encapsulate medicines, direct treatments to the mother, and protect fetuses from potential drug-related harm.
Read at www.cbc.ca
Unable to calculate read time
[
|
]